Horizon Financial Services’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-27
Closed -$1.12K 328
2024
Q4
$1.12K Hold
27
﹤0.01% 208
2024
Q3
$1.8K Hold
27
﹤0.01% 183
2024
Q2
$3.21K Hold
27
﹤0.01% 152
2024
Q1
$2.88K Buy
+27
New +$2.72K ﹤0.01% 164

Other funds holding MRNA

Horizon Financial Services's MRNA Position: Q1 2025 in Review

Horizon Financial Services sold out of Moderna (MRNA) in Q1 2025, closing a stake of 27 shares — an estimated $1.12K sold.

Horizon Financial Services first reported a position in MRNA in Q1 2024 and held it in 4 quarters. The position peaked at $3.21K in Q2 2024. 693 funds tracked by Wall St. Rank hold MRNA as of Q1 2025.

  • Horizon Financial Services reported no remaining Moderna position as of Q1 2025 after selling out during the quarter.
  • Horizon Financial Services sold 27 Moderna shares in Q1 2025, an estimated $1.12K.
  • Horizon Financial Services first reported a position in Moderna in Q1 2024 and held it in 4 quarters.
  • Horizon Financial Services's Moderna position peaked at $3.21K in Q2 2024.
  • 693 funds tracked by Wall St. Rank held Moderna as of Q1 2025.

Based on Horizon Financial Services's 13F filing for Q1 2025, filed 28 Apr 2025.